Theranos reaches settlement with investor Partner Fund Management

Beleaguered blood diagnostics startup Theranos has reached a settlement with hedge fund management firm Partner Fund Management. PFM invested $96.1 million in Theranos’ Series C-2 round in 2014, helping to pop the company up to a $9 billion valuation. However, the hedge fund opened a lawsuit against Theranos last year saying the company had tricked it into investing… Read More